Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab dosing in Chinese subjects with Crohn's Disease
NCT02015793Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Dec 2013
- Primary completion
- Feb 2015
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of adalimumab in Crohn's disease, sponsored by AbbVie Inc.. Started Dec 2013; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02015793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015793.